Birdwatch Note
2025-01-04 19:13:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
A notícia da Folha diz respeito à Butanvac, desenvolvida em parceria com o Hospital Mount Sinai, nos EUA. Já os prints referem-se à vacina Corovac, desenvolvida pela chinesa Sinovac Biotech. https://butantan.gov.br/noticias/vacina-do-butantan-atinge-100-de-eficacia-para-casos-moderados-e-graves https://butantan.gov.br/noticias/butanvac-nao-atinge-desfecho-esperado-e-butantan-interrompe-seu-desenvolvimento
Written by 2C0CC68D031FDC7E69489602065A6CD8684DB312C8D801922E2477912A5036FA
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1875510225085825322
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1875621475648205043
- noteId - 1875621475648205043
- participantId -
- noteAuthorParticipantId - 2C0CC68D031FDC7E69489602065A6CD8684DB312C8D801922E2477912A5036FA Participant Details
- createdAtMillis - 1736017981813
- tweetId - 1875510225085825322
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A notícia da Folha diz respeito à Butanvac, desenvolvida em parceria com o Hospital Mount Sinai, nos EUA. Já os prints referem-se à vacina Corovac, desenvolvida pela chinesa Sinovac Biotech. https://butantan.gov.br/noticias/vacina-do-butantan-atinge-100-de-eficacia-para-casos-moderados-e-graves https://butantan.gov.br/noticias/butanvac-nao-atinge-desfecho-esperado-e-butantan-interrompe-seu-desenvolvimento
Note Ratings
rated at | rated by | |
2025-01-05 03:20:08 -0600 | Rating Details | |
2025-01-04 19:49:43 -0600 | Rating Details | |
2025-01-05 13:50:42 -0600 | Rating Details | |
2025-01-05 07:30:42 -0600 | Rating Details | |
2025-01-05 05:18:27 -0600 | Rating Details | |
2025-01-05 04:38:31 -0600 | Rating Details | |
2025-01-04 19:08:44 -0600 | Rating Details |